Catabasis Pharma's edasalonexent slows rate of functional decline in DMD boys in mid-stage study; shares ahead 29% premarket [Seeking Alpha]
Catabasis Pharmaceuticals, Inc. (CATB)
Last catabasis pharmaceuticals, inc. earnings: 3/10 08:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.catabasis.com/investor-overview
Company Research
Source: Seeking Alpha
Nano cap Catabasis Pharmaceuticals (NASDAQ: CATB ) is up premarket on robust volume in response to the presentation of data from Part B of its Phase 2 clinical trial, MoveDMD, assessing edasalonexent in boys with Duchenne muscular dystrophy (DMD). The results were announced at the American Academy of Neurology 69th Annual Meeting in Boston. In January, the company reported that MoveDMD failed to show a treatment benefit over placebo. The functional data presented at AAN show a numerical improvement, but none are statistically significant since the study was not powered to demonstrate it for these parameters. DMD boys treated with edasalonexent for 12 weeks experienced a 50% slower rate of decline in the 10-meter walk/run test, a 45% slower rate of decline in time to stand and more than 50% reductions in the rates of decline in the 4-stair climb, North Star Ambulatory Assessment and Pediatric Outcomes Data Collection Instrument assessment. The company plans to report i
Show less
Read more
Impact Snapshot
Event Time:
CATB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CATB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CATB alerts
High impacting Catabasis Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics